Sjögren's syndrome-like ocular surface disease in thrombospondin-1 deficient mice

American Journal of Pathology

Volumn 175, Issue 3, 2009, Pages 1136-1147

  Turpie, Bruce ^a   Yoshimura, Takeru ^a   Gulati, Abha ^a,b   Rios, Jose David ^a,c   Dartt, Darlene A ^a   Masli, Sharmila ^a  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^b Ophthalmic Research Associates   (United States)

^c MCLEAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP A ANTIGEN; BLOOD GROUP B ANTIGEN; INTERLEUKIN 17; THROMBOSPONDIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CORNEA EDEMA; CORNEA EPITHELIUM; DRY EYE; GOBLET CELL; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; LACRIMAL FLUID; LACRIMAL GLAND; MOUSE; NONHUMAN; PRIORITY JOURNAL; SJOEGREN SYNDROME; T LYMPHOCYTE ACTIVATION; TH17 CELL; WILD TYPE;

EID: 70349255649     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.081058     Document Type: Article

References (45)

1. Ribeiro SM, Poczatek M, Schultz-Cherry S, Villain M, Murphy-Ullrich JE: The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-beta. J Biol Chem 1999, 274:13586-13593 (Pubitemid 129518577)
2. Lawler J: The functions of thrombospondin-1 and-2. Curr Opin Cell Biol 2000, 12:634-640
3. Crawford SE, Stellmach V, Murphy-Ullrich JE, Ribeiro SM, Lawler J, Hynes RO, Boivin GP, Bouck N: Thrombospondin-1 is a major activator of TGF-beta1 in vivo. Cell 1998, 93:1159-1170 (Pubitemid 28307421)
4. Zamiri P, Masli S, Kitaichi N, Taylor AW, Streilein JW: Thrombospondin plays a vital role in the immune privilege of the eye. Invest Ophthalmol Vis Sci 2005, 46:908-919 (Pubitemid 41321027)
5. Masli S, Turpie B, Streilein JW: Thrombospondin orchestrates the tolerance-promoting properties of TGFbeta-treated antigen-presenting cells. Int Immunol 2006, 18:689-699 (Pubitemid 43779059)
6. McCartney-Francis NL, Mizel DE, Frazier-Jessen M, Kulkarni AB, McCarthy JB, Wahl SM: Lacrimal gland inflammation is responsible for ocular pathology in TGF-beta 1 null mice. Am J Pathol 1997, 151:1281-1288 (Pubitemid 27479758)
7. Nandula SR, Amarnath S, Molinolo A, Bandyopadhyay BC, Hall B, Goldsmith CM, Zheng C, Larsson J, Sreenath T, Chen W, Ambudkar IS, Karlsson S, Baum BJ, Kulkarni AB: Female mice are more susceptible to developing inflammatory disorders due to impaired transforming growth factor beta signaling in salivary glands. Arthritis Rheum 2007, 56:1798-1805
8. Shevach EM, Davidson TS, Huter EN, Dipaolo RA, Andersson J: Role of TGF-beta in the induction of Foxp3 expression and T regulatory cell function. J Clin Immunol 2008, 6:640-646
9. Siemasko KF, Gao J, Calder VL, Hanna R, Calonge M, Pflugfelder SC, Niederkorn JY, Stern ME: In vitro expanded CD4+CD25+Foxp3+ regulatory T cells maintain a normal phenotype and suppress immune-mediated ocular surface inflammation. Invest Ophthalmol Vis Sci 2008, 12:5434-5440
10. Rios JD, Horikawa Y, Chen LL, Kublin CL, Hodges RR, Dartt DA, Zoukhri D: Age-dependent alterations in mouse exorbital lacrimal gland structure, innervation and secretory response. Exp Eye Res 2005, 80:477-491 (Pubitemid 40387516)
11. Rashid S, Jin Y, Ecoiffier T, Barabino S, Schaumberg DA, Dana MR: Topical omega-3 and omega-6 fatty acids for treatment of dry eye. Arch Ophthalmol 2008, 126:219-225 (Pubitemid 351240851)
12. Lemp MA: Report of the National Eye Institute/Industry Workshop on Clinical Trials in Dry Eyes. Clao J 1995, 21:221-232
13. Stern ME, Gao J, Siemasko KF, Beuerman RW, Pflugfelder SC: The role of the lacrimal functional unit in the pathophysiology of dry eye. Exp Eye Res 2004, 78:409-416 (Pubitemid 38183319)
14. Markusse HM, van Haeringen NJ, Swaak AJ, Hogeweg M, de Jong PT: Tear fluid analysis in primary Sjogren's syndrome. Clin Exp Rheumatol 1993, 11:175-178 (Pubitemid 23155988)
15. Doyle ME, Boggs L, Attia R, Cooper LR, Saban DR, Nguyen CQ, Peck AB: Autoimmune dacryoadenitis of NOD/LtJ mice and its subsequent effects on tear protein composition. Am J Pathol 2007, 171:1224-1236 (Pubitemid 47582896)
16. Iwata T, Ohkawa K, Uyama M: The fine structural localization of peroxidase activity in goblet cells of the conjunctival epithelium of rats. Invest Ophthalmol 1976, 15:40-44
17. Nelson JD, Wright JC: Conjunctival goblet cell densities in ocular surface disease. Arch Ophthalmol 1984, 102:1049-1051
18. Korn T, Oukka M, Kuchroo V, Bettelli E: Th17 cells: effector T cells with inflammatory properties. Semin Immunol 2007, 19:362-371 (Pubitemid 351274046)
19. Hoyer KK, Kuswanto WF, Gallo E, Abbas AK: Distinct roles of helper T cell subsets in a systemic autoimmune disease. Blood 2008, 113:389-395
20. Awasthi A, Murugaiyan G, Kuchroo VK: Interplay between effector Th17 and regulatory T cells. J Clin Immunol 2008, 28:660-670
21. De Paiva CS, Chotikavanich S, Pangelinan SB, Pitcher JD, 3rd, Fang B, Zheng X, Ma P, Farley WJ, Siemasko KF, Niederkorn JY, Stern ME, Li DQ, Pflugfelder SC: IL-17 disrupts corneal barrier following desiccating stress. Mucosal Immunol 2009, 3:243-253
22. Chauhan SK, El Annan J, Ecoiffier T, Goyal S, Zhang Q, Saban DR, Dana R: Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression. J Immunol 2009, 182:1247-1252
23. Sakai A, Sugawara Y, Kuroishi T, Sasano T, Sugawara S: Identification of IL-18 and Th17 cells in salivary glands of patients with Sjogren's syndrome, and amplification of IL-17-mediated secretion of inflammatory cytokines from salivary gland cells by IL-18. J Immunol 2008, 181:2898-2906
24. Nguyen CQ, Hu MH, Li Y, Stewart C, Peck AB: Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjogren's syndrome: findings in humans and mice. Arthritis Rheum 2008, 58:734-743
25. Christodoulou MI, Kapsogeorgou EK, Moutsopoulos NM, Moutsopoulos HM: Foxp3+ T-regulatory cells in Sjogren's syndrome. Correlation with the grade of the autoimmune lesion and certain adverse prognostic factors. Am J Pathol 2008, 173:1389-1396
26. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM: Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta. PGE2, and PAF. J Clin Invest 1998, 101:890-898 (Pubitemid 28096086)
27. Nacu N, Luzina IG, Highsmith K, Lockatell V, Pochetuhen K, Cooper ZA, Gillmeister MP, Todd NW, Atamas SP: Macrophages produce TGF-beta-induced (beta-ig-h3) following ingestion of apoptotic cells and regulate MMP14 levels and collagen turnover in fibroblasts. J Immunol 2008, 180:5036-5044
28. Stern ME, Pflugfelder SC: Inflammation in dry eye. Ocul Surf 2004, 2:124-130
29. Pflugfelder SC, Tseng SC, Sanabria O, Kell H, Garcia CG, Felix C, Feuer W, Reis BL: Evaluation of subjective assessments and objective diagnostic tests for diagnosing tear-film disorders known to cause ocular irritation. Cornea 1998, 17:38-56 (Pubitemid 28047008)
30. Perry HD: Dry eye disease: pathophysiology, classification, and diagnosis. Am J Manag Care 2008, 14:S79-87
31. Pflugfelder SC, Jones D, Ji Z, Afonso A, Monroy D: Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjogren's syndrome keratoconjunctivitis sicca. Curr Eye Res 1999, 19:201-211 (Pubitemid 29500267)
32. Jones DT, Monroy D, Ji Z, Pflugfelder SC: Alterations of ocular surface gene expression in Sjogren's syndrome. Adv Exp Med Biol 1998, 438:533-536 (Pubitemid 28303785)
33. Tiffany JM: The normal tear film. Dev Ophthalmol 2008, 41:1-20
34. Li Y, Kuang K, Yerxa B, Wen Q, Rosskothen H, Fischbarg J: Rabbit conjunctival epithelium transports fluid, and P2Y2(2) receptor agonists stimulate Cl(-) and fluid secretion. Am J Physiol Cell Physiol 2001, 281:C595-C602
35. Tsubota K, Xu KP, Fujihara T, Katagiri S, Takeuchi T: Decreased reflex tearing is associated with lymphocytic infiltration in lacrimal glands. J Rheumatol 1996, 23:313-320 (Pubitemid 26079224)
36. Tsubota K, Kaido M, Yagi Y, Fujihara T, Shimmura S: Diseases associated with ocular surface abnormalities: the importance of reflex tearing. Br J Ophthalmol 1999, 83:89-91 (Pubitemid 29106339)
37. Ding C, Walcott B, Keyser KT: Sympathetic neural control of the mouse lacrimal gland. Invest Ophthalmol Vis Sci 2003, 44:1513-1520 (Pubitemid 36378576)
38. Soyfoo MS, Steinfeld S, Delporte C: Usefulness of mouse models to study the pathogenesis of Sjogren's syndrome. Oral Dis 2007, 13:366-375 (Pubitemid 46934581)
39. Jonsson MV, Delaleu N, Brokstad KA, Berggreen E, Skarstein K: Impaired salivary gland function in NOD mice: association with changes in cytokine profile but not with histopathologic changes in the salivary gland. Arthritis Rheum 2006, 54:2300-2305 (Pubitemid 44051088)
40. Paranyuk Y, Claros N, Birzgalis A, Moore LC, Brink PR, Walcott B: Lacrimal gland fluid secretion and lymphocytic infiltration in the NZB/W mouse model of Sjogren's syndrome. Curr Eye Res 2001, 23:199-205 (Pubitemid 34497360)
41. Mircheff AK, Xie J, Qian L, Hamm-Alvarez SF: Diverse perturbations may alter the lacrimal acinar cell autoantigenic spectra. DNA Cell Biol 2002, 21:435-442 (Pubitemid 35034586)
42. Mircheff AK: Sjogrens syndrome as failed local immunohomeostasis: prospects for cell-based therapy. Ocul Surf 2003, 1:160-179
43. Vogelsang P, Jonsson MV, Dalvin ST, Appel S: Role of dendritic cells in Sjogren's syndrome. Scand J Immunol 2006, 64:219-226 (Pubitemid 44215111)
44. Chaparro RJ, Konigshofer Y, Beilhack GF, Shizuru JA, McDevitt HO, Chien YH: Nonobese diabetic mice express aspects of both type 1 and type 2 diabetes. Proc Natl Acad Sci USA 2006, 103:12475-12480 (Pubitemid 44267284)
45. Schenke-Layland K, Xie J, Angelis E, Starcher B, Wu K, Riemann I, MacLellan WR, Hamm-Alvarez SF: Increased degradation of extracellular matrix structures of lacrimal glands implicated in the pathogenesis of Sjogren's syndrome. Matrix Biol 2008, 27:53-66